SEARCH

SEARCH BY CITATION

References

  • BLIER, P. & DE MONTIGNY, C. (1994). Current advances and trends in the treatment of depression. Trends Pharmacol. Sci., 15, 220226.
  • CACCIA, S. (1998). Metabolism of newer antidepressants. An overview of the pharmacological and pharmacokinetics implications. Clin. Pharmacokinet., 34, 281302.
  • CAMPBELL, I.C. & MCKERNAN, R.M. (1986). Clorgyline and desipramine alter the sensitivity of [3H]-noradrenaline release to calcium but not to clonidine. Brain Res., 372, 253259.
  • CARBONI, E., TANDA, G., FRAU, R. & DI CHIARA, G. (1990). Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem., 55, 10671070.
  • DENNIS, T., L'HEUREUX, R., CARTER, C. & SCATTON, B. (1987). Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J. Pharmacol. Exp. Ther., 241, 642649.
  • DOSTERT, P., BENEDETTI, M.S. & POGGESI, I. (1997). Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor. Eur. Neuropsychopharmacol., 7, (Suppl. 1) S23S35.
  • EDWARDS, D.M.F., PELLIZZONI, C., BREUEL, H.P., BERARDI, A., CASTELLI, M.G., FRIGERIO, E., POGGESI, I., ROCCHETTI, M., DUBINI, A. & STROLIN BENEDETTI, M. (1995). Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding. Biopharm. Drug Disp., 16, 443460.
  • FRIGERIO, E., PIANEZZOLA, E. & STROLIN BENEDETTI, M. (1994). Sensitive procedure for the determination of reboxetine enantiomers in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detection after chiral derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate. J. Chromatog. A, 660, 351358.
  • HEAL, D.J., PROW, M.R. & BUCKETT, W.R. (1991). Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology, 103, 251257.
  • INVERNIZZI, R., BELLI, S. & SAMANIN, R. (1992). Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res., 584, 322324.
  • KAPUR, S. & MANN, J.J. (1992). Role of the dopaminergic system in depression. Biol. Psychiatry, 32, 117.
  • LACROIX, D., BLIER, P., CURET, O. & DE MONTIGNY, C. (1991). Effect of long-term desipramine administration on noradrenergic neurotransmission: electro-physiological studies in the rat brain. J. Pharmacol. Exp. Ther., 257, 10811090.
  • MATEO, Y., PINEDA, J. & MEANA, J.J. (1998). Somatodendritic α2-adrenoceptors in the locus coeruleus are involved in the in vivo modulation of cortical noradrenaline release by the antidepressant desipramine. J. Neurochem., 71, 790798.
  • PALIJ, P. & STAMFORD, J.A. (1996). Rauwolscine potentiates the effect of desipramine on limbic noradrenaline efflux. Neuroreport, 7, 11211124.
  • PAXINOS, G. & WATSON, C. (1982). The rat brain in stereotaxic coordinates, Academic Press: Sydney.
  • POZZI, L., INVERNIZZI, R., CERVO, L., VALLEBUONA, F. & SAMANIN, R. (1994). Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem., 63, 195200.
  • ROBINSON, T.E. & WHISHAW, I.Q. (1988). Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res., 450, 209224.
  • SACCHETTI, G., BERNINI, M., BIANCHETTI, A., PARINI, S., INVERNIZZI, R.W. & SAMANIN, R. (1999). Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br.J.Pharmacol., 128, 13321338.
  • SACCHETTI, G., BERNINI, M., GOBBI, M., PARINI, S., PIRONA, L., MENNINI, T. & SAMANIN, R. (2000). Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic α2-adrenoceptors. N.S. Arch. Pharmacol., 363, 6672.
  • SCHOFFELMEER, A.N.M. & MULDER, A.H. (1982). 3HNoradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic α-adrenergic modulation after long-term desipramine pretreatment. N.S. Arch. Pharmacol., 318, 173180.
  • WONG, E.H.F., SONDERS, M.S., AMARA, S.G., TINHOLT, P.M., PIERCEY, M.F.P., HOFFMANN, W.P., HYSLOP, D.K., FRANKLIN, S., PORSOLT, R.D., BONSIGNORI, A., CARFAGNA, N. & MCARTHUR, R.A. (2000). Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry, 47, 818829.